Medical devices, healthcare technology and the business of care
PMA approval · P100047

HEARTWARE VENTRICULAR ASSIST SYSTEM

Medtronic · Decision date Nov 20, 2012

FDA DECISIONP100047

What did the FDA approve?

FDA records P100047 as an original PMA application. The recorded decision is approval, dated Nov 20, 2012.

FDA approval order statement

APPROVAL FOR THE HEARTWARE VENTRICULAR ASSIST SYSTEM (VAS). THIS DEVICE IS INDICATED FOR USE AS A BRIDGE TO CARDIAC TRANSPLANTATION IN PATIENTS WHO ARE AT RISK OF DEATH FROM REFRACTORY END-STAGE LEFT VENTRICULAR HEART FAILURE. THE HEART WARE VAS IS DESIGNED FOR IN-HOSPITAL AND OUT-OF-HOSPITAL SETTINGS, INCLUDING TRANSPORTATION VIA FIXED WING AIRCRAFT OR HELICOPTER.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Nov 20, 2012

FDA source record

Regulatory record facts

Identifier
P100047
Regulatory pathway
Premarket approval application
Applicant
Medtronic
Product code
DSQ
Decision code
APPR
Decision date
Nov 20, 2012
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Medtronic
Product code
DSQ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P100047 received

    Application receipt date recorded by FDA.

  2. P100047 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P100047. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100047

Product / regulatory recordCompanyPathwayDecision dateSource
MedtronicPMA supplementSep 23, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records